As 2024 draws to a close, Archbow Consulting reflects on a year of dynamic change within the pharmaceutical industry.

BLOG
As 2024 draws to a close, Archbow Consulting reflects on a year of dynamic change within the pharmaceutical industry.
As the world becomes increasingly digitized, a novel idea of a virtual third-party logistics (3PL) vendor has been established in the pharmaceutical industry.
Hub Implementation: The Key to Product Launches
Revving Up for 2024: Market Access Kick-Start Resources
Prior Authorization Should be a Top Concern for Pharma — Here’s Why
The Perils of Pull-Through
How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
Take the Pain out of Conversations About Coverage
How Manufacturers Can Optimize Hub Services
What market access teams should be thinking about after 2023’s SXSW Conference
Manufacturers recognize access and affordability programs as key differentiators that build brand loyalty with elevated customer experiences
Manufacturers recognize access and affordability programs as key differentiators that build brand loyalty with elevated customer experiences
For manufacturers who haven’t started preparing for DSCSA D-Day, the “OH NO!” moment is here, but this article can help.
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today